Clinical Trial: A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695597) titled 'A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia' on July 06.

Brief Summary: This is a randomized, double-blind, placebo-parallel, multicenter phase II clinical trial to evaluate the efficacy and safety of SYH2070 injection in participants with mixed hyperlipidemia.

Study Start Date: July 17

Study Type: INTERVENTIONAL

Condition: Mixed Hyperlipidemia

Intervention: DRUG: SYH2070

SYH2070 injection, 150 mg, 300 mg, 400 mg, SC, administration duration: 24 weeks

DRUG: Placebo

Placebo, SC, administration duration: 24 weeks

Recruitment Status: NOT_YET_RECRUITING

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiaz...